255 related articles for article (PubMed ID: 17549457)
41. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
[TBL] [Abstract][Full Text] [Related]
42. [Guidelines for treatment of pneumonia in intensive care units].
Emmi V
Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
[TBL] [Abstract][Full Text] [Related]
43. Nebulised colistin for ventilator-associated pneumonia prevention.
Karvouniaris M; Makris D; Zygoulis P; Triantaris A; Xitsas S; Mantzarlis K; Petinaki E; Zakynthinos E
Eur Respir J; 2015 Dec; 46(6):1732-9. PubMed ID: 26405294
[TBL] [Abstract][Full Text] [Related]
44. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit.
Djordjevic ZM; Folic MM; Jankovic SM
J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513
[TBL] [Abstract][Full Text] [Related]
45. The efficiency of routine endotracheal aspirate cultures compared to bronchoalveolar lavage cultures in ventilator-associated pneumonia diagnosis.
Yagmurdur H; Tezcan AH; Karakurt O; Leblebici F
Niger J Clin Pract; 2016; 19(1):46-51. PubMed ID: 26755218
[TBL] [Abstract][Full Text] [Related]
46. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
47. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
[TBL] [Abstract][Full Text] [Related]
48. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
Sathe P; Maddani S; Kulkarni S; Munshi N
J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
[TBL] [Abstract][Full Text] [Related]
49. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
[TBL] [Abstract][Full Text] [Related]
50. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
Abdelsalam MFA; Abdalla MS; El-Abhar HSE
J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
[TBL] [Abstract][Full Text] [Related]
51. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study.
Nseir S; Di Pompeo C; Diarra M; Brisson H; Tissier S; Boulo M; Durocher A
Crit Care Med; 2007 May; 35(5):1318-23. PubMed ID: 17414081
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Risk Factors in Ventilator-Associated Pneumonia.
Karakuzu Z; Iscimen R; Akalin H; Kelebek Girgin N; Kahveci F; Sinirtas M
Med Sci Monit; 2018 Mar; 24():1321-1328. PubMed ID: 29503436
[TBL] [Abstract][Full Text] [Related]
53. Infections in a surgical intensive care unit of a university hospital in Greece.
Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
[TBL] [Abstract][Full Text] [Related]
54. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
[TBL] [Abstract][Full Text] [Related]
55. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
[TBL] [Abstract][Full Text] [Related]
56. Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Crouch Brewer S; Wunderink RG; Jones CB; Leeper KV
Chest; 1996 Apr; 109(4):1019-29. PubMed ID: 8635325
[TBL] [Abstract][Full Text] [Related]
57. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.
Agodi A; Barchitta M; Cipresso R; Giaquinta L; Romeo MA; Denaro C
Intensive Care Med; 2007 Jul; 33(7):1155-1161. PubMed ID: 17503016
[TBL] [Abstract][Full Text] [Related]
58. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
59. A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.
Suarez C; Peña C; Arch O; Dominguez MA; Tubau F; Juan C; Gavaldá L; Sora M; Oliver A; Pujol M; Ariza J
BMC Infect Dis; 2011 Oct; 11():272. PubMed ID: 21995287
[TBL] [Abstract][Full Text] [Related]
60. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients.
Ortega B; Groeneveld AB; Schultsz C
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):825-31. PubMed ID: 15518023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
